Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 May 2022 07:00 AM
RNS
Challenge virus manufacturing contract
04 May 2022 07:00 AM
RNS
Comment re: speculation
28 Apr 2022 07:00 AM
RNS
Appointment of Nominated Adviser and Joint Broker
13 Apr 2022 07:00 AM
RNS
Proposal to Distribution in Specie Shareholders
12 Apr 2022 12:00 PM
RNS
Presentation at World Vaccine Congress
06 Apr 2022 04:35 PM
RNS
Price Monitoring Extension
06 Apr 2022 02:05 PM
RNS
Second Price Monitoring Extn
06 Apr 2022 02:01 PM
RNS
Price Monitoring Extension
06 Apr 2022 11:05 AM
RNS
Second Price Monitoring Extn
06 Apr 2022 11:00 AM
RNS
Price Monitoring Extension
31 Mar 2022 10:05 AM
RNS
Characterisation Study results in Nature Medicine
25 Mar 2022 07:00 AM
RNS
£5m RSV human challenge study contract win
09 Mar 2022 04:41 PM
RNS
Second Price Monitoring Extn
09 Mar 2022 04:37 PM
RNS
Price Monitoring Extension
08 Mar 2022 07:00 AM
RNS
Trading Update and screening facilities expansion
07 Mar 2022 02:06 PM
RNS
Second Price Monitoring Extn
07 Mar 2022 02:00 PM
RNS
Price Monitoring Extension
07 Mar 2022 11:06 AM
RNS
Second Price Monitoring Extn
07 Mar 2022 11:00 AM
RNS
Price Monitoring Extension
02 Mar 2022 07:00 AM
RNS
Investor Presentations
24 Feb 2022 07:00 AM
RNS
CEO Appointment
22 Feb 2022 07:00 AM
RNS
FDA Breakthrough Designation for Big Pharma RSV
17 Feb 2022 12:05 PM
RNS
Positive results from RSV Human Challenge Study
14 Feb 2022 07:00 AM
RNS
Launch of STRiVE project
02 Feb 2022 07:00 AM
RNS
World's first COVID-19 Characterisation Study
26 Jan 2022 04:40 PM
RNS
Second Price Monitoring Extn
26 Jan 2022 04:36 PM
RNS
Price Monitoring Extension
20 Jan 2022 07:00 AM
RNS
Malaria Human Challenge Model Launched
21 Dec 2021 07:00 AM
RNS
£5m Influenza human challenge study contract win
16 Dec 2021 04:41 PM
RNS
Second Price Monitoring Extn
16 Dec 2021 04:35 PM
RNS
Price Monitoring Extension
10 Dec 2021 11:05 AM
RNS
Second Price Monitoring Extn
10 Dec 2021 11:00 AM
RNS
Price Monitoring Extension
10 Dec 2021 07:05 AM
RNS
Exercise of Options
10 Dec 2021 07:00 AM
RNS
$13.4m Influenza HCS contract win
06 Dec 2021 07:00 AM
RNS
Positive results from Flu Human Challenge Study
19 Nov 2021 07:00 AM
RNS
Imutex Vaccine Phase I Study Results
17 Nov 2021 07:00 AM
RNS
£5.1m RSV contract
15 Nov 2021 07:00 AM
RNS
£1.5m Contract renewal for Venn Life Sciences
13 Oct 2021 07:00 AM
RNS
Directorate Change
20 Sep 2021 07:00 AM
RNS
Half-year Report
20 Sep 2021 07:00 AM
RNS
£5.7m Influenza human challenge study contract win
09 Sep 2021 07:00 AM
RNS
Notice of Results
07 Sep 2021 07:00 AM
RNS
Positive results from RSV Human Challenge Study
24 Aug 2021 09:05 AM
RNS
Second Price Monitoring Extn
24 Aug 2021 09:00 AM
RNS
Price Monitoring Extension
24 Aug 2021 07:00 AM
RNS
£8.1m Asthma Human Challenge Study Contract Win
09 Aug 2021 07:00 AM
RNS
Malaria Human Challenge Model
29 Jul 2021 07:00 AM
RNS
DNDi Phase II trial support
22 Jul 2021 07:00 AM
RNS
NEJM Opinion Piece
UK 100

Latest directors dealings